Cargando…

An Adjudication Protocol for Severe Pneumonia

BACKGROUND: Clinical end points that constitute successful treatment in severe pneumonia are difficult to ascertain and vulnerable to bias. The utility of a protocolized adjudication procedure to determine meaningful end points in severe pneumonia has not been well described. METHODS: This was a sin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pickens, Chiagozie I, Gao, Catherine A, Bodner, Justin, Walter, James M, Kruser, Jacqueline M, Donnelly, Helen K, Donayre, Alvaro, Clepp, Katie, Borkowski, Nicole, Wunderink, Richard G, Singer, Benjamin D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372865/ https://www.ncbi.nlm.nih.gov/pubmed/37520413 http://dx.doi.org/10.1093/ofid/ofad336

Ejemplares similares

Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19
por: Gao, Catherine A., et al.
Publicado: (2023)

A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia()()()
por: Pickens, Chiagozie, et al.
Publicado: (2020)

Clinical significance of culture-negative, PCR-positive bronchoalveolar lavage results in severe pneumonia
por: Rabin, Erik E., et al.
Publicado: (2023)

Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
por: Grant, Rogan A., et al.
Publicado: (2021)

Antibiotic‐resistant bacteria: COVID‐19 hasn't made the challenge go away
por: Waterer, Grant, et al.
Publicado: (2021)

Finding Facts in Postacute Sequelae of COVID-19: Clinical, Radiographic, and Histopathologic Markers of Disease
por: Pickens, Chiagozie I., et al.
Publicado: (2023)

Gearing up for battle: Harnessing adaptive T cell immunity against gram-negative pneumonia
por: Gao, Catherine A., et al.
Publicado: (2022)

Concordance Between Initial Presumptive and Final Adjudicated Diagnoses of Infection Among Patients Meeting Sepsis-3 Criteria in the Emergency Department
por: Hooper, Gabriel A, et al.
Publicado: (2023)

Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States
por: Diaz, Maureen H., et al.
Publicado: (2015)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia
por: Pickens, Chiagozie O., et al.
Publicado: (2021)

To Adjudicate or Not Adjudicate: That Is the Question
por: Hicks, Karen A., et al.
Publicado: (2022)

Impact of Streptococcus pneumoniae Urinary Antigen Testing in Patients With Community-Acquired Pneumonia Admitted Within a Large Academic Health System
por: Greenfield, Adam, et al.
Publicado: (2021)

Normal Respiratory Flora as a Cause of Community-Acquired Pneumonia
por: Musher, Daniel M, et al.
Publicado: (2020)

Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia
por: Nolan, Vikki G, et al.
Publicado: (2018)

Improved Diagnostics Help to Identify Clinical Features and Biomarkers That Predict Mycoplasma pneumoniae Community-acquired Pneumonia in Children
por: Meyer Sauteur, Patrick M, et al.
Publicado: (2019)

Candida Pneumonia in Intensive Care Unit?
por: Schnabel, Ronny M., et al.
Publicado: (2014)

Source and Relevance of the BK Polyomavirus Genotype for Infection After Kidney Transplantation
por: Wunderink, H F, et al.
Publicado: (2019)

Microbiology Comment Nudge Improves Pneumonia Prescribing
por: Musgrove, Mary A, et al.
Publicado: (2018)

Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults
por: Isturiz, Raul, et al.
Publicado: (2021)

White Blood Cell Counts, Alcoholism, and Cirrhosis in Pneumococcal Pneumonia
por: Gardner, Julianna G., et al.
Publicado: (2017)

Epidemiology and Outcomes of Community-Acquired Escherichia coli Pneumonia
por: John, Teny M, et al.
Publicado: (2021)

Gut Microbiota and Clinical Features Distinguish Colonization With Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae at the Time of Admission to a Long-term Acute Care Hospital
por: Seekatz, Anna M, et al.
Publicado: (2018)

Association Between the Order of Macrolide and Cephalosporin Treatment and Outcomes of Pneumonia
por: Metersky, Mark L, et al.
Publicado: (2017)

Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2023)

Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials
por: Alexander, Elizabeth L., et al.
Publicado: (2017)

Clinical Features and Outcomes of Community-Acquired Pneumonia Caused by Haemophilus influenzae
por: Shoar, Saeed, et al.
Publicado: (2021)

Dynamics of Colonization of Streptococcus pneumoniae Strains in Healthy Peruvian Children
por: Nelson, Kristin N, et al.
Publicado: (2018)

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Clinical Utilization of DiaSorin Molecular Polymerase Chain Reaction in Pneumocystis Pneumonia
por: Damhorst, Gregory L, et al.
Publicado: (2022)

Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019( )
por: Certan, Maria, et al.
Publicado: (2022)

Practice Patterns of Pneumocystis Pneumonia Prophylaxis in Connective Tissue Diseases: A Survey of Infectious Disease Physicians
por: Wolfe, Rachel M, et al.
Publicado: (2019)

Long-term Care Facility Variation in the Incidence of Pneumonia and Influenza
por: Bosco, Elliott, et al.
Publicado: (2019)

Hepcidin and Ferritin Predict Microbial Etiology in Community-Acquired Pneumonia
por: Oppen, Kjersti, et al.
Publicado: (2021)

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
por: Mandell, Lionel A, et al.
Publicado: (2022)

Prevalence of Klebsiella pneumoniae carbapenemase - and New Delhi metallo-beta-lactamase-positive K. pneumoniae in Sergipe, Brazil, and combination therapy as a potential treatment option
por: Vivas, Roberto, et al.
Publicado: (2020)

Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Carbapenemase–Producing Klebsiella pneumoniae Infections: A Retrospective, Observational, 2-Center Clinical Study
por: Oliva, Alessandra, et al.
Publicado: (2023)

Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial
por: Malchair, Pierre, et al.
Publicado: (2023)

Implementation of a Rapid Multiplex Polymerase Chain Reaction Pneumonia Panel and Subsequent Antibiotic De-escalation
por: Miller, Molly M, et al.
Publicado: (2023)

Macrolide Resistance, Clinical Features, and Cytokine Profiles in Taiwanese Children With Mycoplasma pneumoniae Infection
por: Wu, Tsung-Hua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_raubqrjmb8skfufvaeb87vve97